ALENDROVENIR

Country: Israel

Language: English

Source: Ministry of Health

Buy It Now

Active ingredient:

ALENDRONIC ACID AS SODIUM 70 MG

Available from:

BIOAVENIR LTD

ATC code:

M05BA04

Pharmaceutical form:

TABLETS

Administration route:

PER OS

Manufactured by:

WEST PHARMA- PROD. DE ESPEC. FARMACEUT.S.A.

Therapeutic group:

ALENDRONIC ACID

Therapeutic indications:

Alendronate Bioavenir is indicated for the treatment of osteoporosis in postmenopausal women to prevent fractures, including those of the hip and spine (vertebral compression fractures) .

Authorization date:

2010-03-01

Search alerts related to this product

View documents history